Roger Matheu

Hospital Clínic de Barcelona

Papers

1

Total Citations

19

H-Index

1

About

Roger Matheu is a urologic surgeon and researcher whose work focuses on improving outcomes in prostate cancer surgery, particularly through the lens of robotic-assisted radical prostatectomy. His key research area centers on the prognostic significance of positive surgical margins (PSM) and their nuanced impact on biochemical recurrence (BCR) risk. In his most cited work, Matheu demonstrates that not all PSMs carry the same prognosis, meticulously analyzing how different margin characteristics and their coexistence influence recurrence likelihood. This contribution provides critical insight for surgical planning and postoperative risk stratification, helping clinicians tailor follow-up and adjuvant therapy decisions. With 19 citations on this landmark paper, his findings are gaining traction among urologic oncology peers. Matheu’s research bridges the gap between surgical technique and oncologic outcomes, offering actionable data that refines our understanding of margin significance beyond a binary positive-or-negative classification. His work is particularly valuable for trainees and surgeons seeking to optimize nerve-sparing approaches while minimizing recurrence risk, cementing his role as a thoughtful contributor to evidence-based prostate cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
19
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
The Effect of Adverse Surgical Margins on the Risk of Biochemical Recurrence after Robotic-Assisted Radical Prostatectomy
19 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Hospital Clínic de Barcelona

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago